Xenon Pharmaceuticals Inc
For the period ended Dec 31, 2023. Filed Feb 29, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 29, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
POWER OF ATTORNEY
Each person whose signature appears below hereby constitutes and appoints Simon Pimstone, Ian Mortimer and Sherry Aulin, and each of them severally, as his or her true and lawful attorneys-in-fact and agents, with full power to act without the other and with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities (including his or her capacity as a director and/or officer of Xenon Pharmaceuticals Inc.) to sign any and all amendments and supplements to this report, and any and all other instruments necessary or incidental in connection herewith, and to file the same, with all exhibits thereto, and all other documents in connection therewith, with the Commission.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ Ian MortimerIan Mortimer | President, Chief Executive Officer and Director (Principal Executive Officer) | February 29, 2024 |
| /s/ Sherry Aulin | Chief Financial Officer (Principal Financial and Accounting Officer) | February 29, 2024 |
| Sherry Aulin | ||
| /s/ Simon Pimstone | Chair of the Board of Directors | February 29, 2024 |
| Simon Pimstone | ||
| /s/ Mohammad Azab | Director | February 29, 2024 |
| Mohammad Azab | ||
| /s/ Gillian Cannon | Director | February 29, 2024 |
| Gillian Cannon | ||
| /s/ Steven Gannon | Director | February 29, 2024 |
| Steven Gannon | ||
| /s/ Elizabeth Garofalo | Director | February 29, 2024 |
| Elizabeth Garofalo | ||
| /s/ Justin Gover | Director | February 29, 2024 |
| Justin Gover | ||
| /s/ Patrick Machado | Director | February 29, 2024 |
| Patrick Machado | ||
| /s/ Gary Patou | Director | February 29, 2024 |
| Gary Patou | ||
| /s/ Dawn Svoronos | Director | February 29, 2024 |
| Dawn Svoronos | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.